8 employees
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
2016
$500K
from 1 investors over 1 rounds
MindImmune Therapeutics, Inc. raised $500K on July 14, 2016
Investors: Slater Technology Fund